185Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Australia
Neuroscience Intelligence
Australia neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #9 of 50 · Data maturity A · Research score 45.3 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
56Recruiting trials
486Publications
236Institutions
Executive interpretation
Australia ranks #9 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC177 recruiting
Hoffmann-La Roche124 recruiting
Pfizer61 recruiting
AbbVie60 recruiting
Eli Lilly and Company50 recruiting
Novartis Pharmaceuticals41 recruiting
Eisai Inc.42 recruiting
Biogen41 recruiting
Novo Nordisk A/S42 recruiting
The University of Queensland41 recruiting
Disease activity
Alzheimers37trials
Parkinsons28trials
Epilepsy22trials
Stroke12trials
Autism11trials
Depression8trials
Neuromuscular8trials
Other Neurology6trials
Multiple Sclerosis4trials
Pain Neuropathy3trials
Research institutions
University of CanberraOpenAlexlinked institution
Data61OpenAlexlinked institution
Nepean HospitalOpenAlexlinked institution
Murdoch UniversityOpenAlexlinked institution
Cooperative Research Centre for Mental HealthOpenAlexlinked institution
Repatriation General HospitalOpenAlexlinked institution
SA HealthOpenAlexlinked institution
Dandenong HospitalOpenAlexlinked institution
Government of Western AustraliaOpenAlexlinked institution
Bionics InstituteOpenAlexlinked institution
Clinical evidence trail
NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)RECRUITING
NCT07339423AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightRECRUITING
NCT07304154A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesRECRUITING
NCT07257978Efficacy and Safety of NTI164 in Children and Young Adults With Rett SyndromeNOT_YET_RECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
NCT07033494A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)RECRUITING
NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineACTIVE_NOT_RECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06961006A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)RECRUITING
Research evidence trail
PUBMEDProspective associations of depression and anxiety symptoms with the transition from suicidal ideation to attempt over 18 months.2026-12-15
PUBMEDMental health predictors of treatment engagement and completion in substance use disorder treatment: Within- and between-person evidence from a 15-year Western Australian cohort.2026-12-01
PUBMEDUnderstanding mental health needs in Ukraine: protocol for a longitudinal survey of mental health in children and caregivers during the war in Ukraine.2026-12-01
PUBMEDIntegrated exposure-based therapy for co-occurring post-traumatic stress and substance use among young people: a randomized controlled trial.2026-12-01
PUBMEDBrief internet intervention for grieving children and adolescents: co-design and trial protocol.2026-12-01
PUBMEDSupporting kids in loss: A randomised controlled trial of a co-produced unguided internet cognitive behaviour therapy intervention for grieving children.2026-12-01
PUBMEDIncorporating advanced neuroscience research in undergraduate neuroscience education.2026-12-01
PUBMEDCognitive trajectories in the nine months following recent-onset major depressive disorder.2026-12-01
PUBMEDExamining the utility of digital phenotyping for the prediction of intrusive experiences.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.